Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed) is sponsored by National Institute on Drug Abuse (NIDA). This NIH funding opportunity supports research to reduce HIV/AIDS among alcohol-impacted populations through innovative interventions and implementation science, and mechanisms and targets at the intersection of HIV and substance use.

Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) - Federal Grant Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) The summary for the Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) grant is detailed below.

This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants. com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact .

If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed): The purpose of this FOA is to support basic research on signaling pathways and mechanisms including HIV-host protein interactions and post-translational modifications by which addictive drugs and HIV infection converge to induce changes in brain function and cause neuropathological alterations and neurocognitive dysfunctions.

This FOA also aims to promote discovery and development of novel chemical and biological approaches for prevention or mitigation of CNS complications associated with HIV infection and substance use disorders.

Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) National Institutes of Health (HHS-NIH11) Funding Opportunity Number: Current Application Deadline: Original Application Deadline: Maximum Federal Grant Award: Minimum Federal Grant Award: Expected Number of Awards: Cost Sharing or Matching: Applicants Eligible for this Grant State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)

Additional Information on Eligibility Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Link to Full Grant Announcement https://grants. nih. gov/grants/guide/rfa-files/RFA-DA-24-013.

html Grant Announcement Contact See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. Similar Government Grants • Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional) • Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on H...

• Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeu... • CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical... • Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research...

• NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards • Drug Abuse Aspects of Hiv/Aids and Other Infections • Epidemiology of Drug Abuse More Grants from the National Institutes of Health • Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella... • Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability P...

• GREGoRi Innovation Projects (U01 Clinical Trial Optional) • GREGoRi Technology Integration Center (U01, Clinical Trials Optional) • GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed) Federal Grants by Category Grants for Single Mothers Small Business Grants for Women Federal Grants for College Federal Tuition Assistance